Literature DB >> 14662729

Changes in rectal temperature and ECoG spectral power of sensorimotor cortex elicited in conscious rabbits by i.c.v. injection of GABA, GABA(A) and GABA(B) agonists and antagonists.

Maria Frosini1, Massimo Valoti, Giampietro Sgaragli.   

Abstract

1. In order to ascertain whether both GABA(A) and GABA(B), or only GABA(B) receptors, directly modulate thermoregulation in conscious rabbits, GABA(A)/GABA(B) agonist and antagonist agents were injected intracerebroventricularly in conscious rabbits while monitoring changes in rectal temperature (RT), gross motor behaviour (GMB) and electrocorticogram (ECoG) power spectra (ps) from sensorimotor cortices. 2. GABA (48 micromol), nipecotic acid (50 nmol), THIP (60 nmol), muscimol (18 nmol) and baclofen (8 nmol) induced hypothermia (-deltaRTmax values of 1.70+/-0.1, 1.4+/-0.2, 1.0+/-0.4, 1.1+/-0.2 and 1.6+/-0.3 degrees C, respectively), accompanied by inhibition of GMB and ECoG synchronization. THIP increased ps at delta frequency band (1.1-3.3 Hz), while GABA, nipecotic acid, muscimol and baclofen did the same at both delta and (4.6-6.5 Hz) frequency bands. ECoG ps changes were concomitant or even preceded hypothermia. 3. Bicuculline (1.8 nmol) induced hyperthermia (deltaRTmax 1.2+/-0.5 degrees C) and slight excitation of GMB, while CGP35348 (1.2 micromol) did not affect RT nor GMB. Both compounds did not affect ECoG ps. 4. Bicuculline potentiated muscimol-induced hypothermia, inhibition of GMB and synchronization of ECoG, while CGP35348 fully antagonized these effects. 5. In conclusion, the present results, while confirming the prevailing role of GABA(B), also outline a direct involvement of GABA(A) receptors in the central mechanisms of thermoregulation. Ascending inhibition towards discrete cortical areas controlling muscular activity and thermogenesis may result from GABA receptor activation in neurones proximal to the ventricles, thus contributing to hypothermia, although hypothermia-induced reduction of neuronal activity of these cortical areas cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662729      PMCID: PMC1574176          DOI: 10.1038/sj.bjp.0705593

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature.

Authors:  B N Mallick; M N Alam
Journal:  Brain Res       Date:  1992-09-18       Impact factor: 3.252

2.  Medial preoptic area affects sleep-wakefulness independent of associated body temperature change in free moving rats.

Authors:  B N Mallick; M N Alam
Journal:  Brain Res Bull       Date:  1991-02       Impact factor: 4.077

Review 3.  Keeping cool: a hypothesis about the mechanisms and functions of slow-wave sleep.

Authors:  D McGinty; R Szymusiak
Journal:  Trends Neurosci       Date:  1990-12       Impact factor: 13.837

4.  Opioid and prostaglandin mechanisms involved in the effects of GABAergic drugs on body temperature.

Authors:  M Sancibrian; J S Serrano; F J Miñano
Journal:  Gen Pharmacol       Date:  1991

5.  Arousal state vs. temperature effects on neuronal activity in subcoeruleus area.

Authors:  D A Grahn; C M Radeke; H C Heller
Journal:  Am J Physiol       Date:  1989-04

6.  Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.

Authors:  B Ferger; W Kropf; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

7.  Activity of preoptic neurons during synchronization and desynchronization.

Authors:  B N Mallick; G S Chhina; K R Sundaram; B Singh; V M Kumar
Journal:  Exp Neurol       Date:  1983-09       Impact factor: 5.330

8.  Inhibition of baclofen-induced hypothermia in mice by the novel GABAB antagonist CGP 35348.

Authors:  H C Jackson; D J Nutt
Journal:  Neuropharmacology       Date:  1991-05       Impact factor: 5.250

9.  GABAergic system inducing hyperthermia in the rat preoptic area: its independence of prostaglandin E2 system.

Authors:  P G Osborne; H Onoe; Y Watanabe
Journal:  Brain Res       Date:  1994-10-24       Impact factor: 3.252

10.  Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.

Authors:  G Bagetta; G B De Sarro; S Sakurada; V Rispoli; G Nisticò
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

View more
  6 in total

1.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

Review 2.  Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

Authors:  Rishabh Charan Choudhary; Xiaofeng Jia
Journal:  Ther Hypothermia Temp Manag       Date:  2017-05-03       Impact factor: 1.286

3.  Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2011-10-04       Impact factor: 4.492

4.  Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2012-06-13       Impact factor: 4.492

5.  Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.

Authors:  Joshua A Lile; Thomas H Kelly; David J Pinsky; Lon R Hays
Journal:  Psychopharmacology (Berl)       Date:  2008-11-19       Impact factor: 4.530

6.  Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.

Authors:  Christiaan H Vinkers; Marianne Klanker; Lucianne Groenink; S Mechiel Korte; James M Cook; Michael L Van Linn; Seth C Hopkins; Berend Olivier
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.